FMP

FMP

Enter

ATNF - 180 Life Sciences Co...

Financial Summary of 180 Life Sciences Corp.(ATNF), 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet me

photo-url-https://financialmodelingprep.com/image-stock/ATNF.png

180 Life Sciences Corp.

ATNF

NASDAQ

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

1.82 USD

-0.0099 (-0.544%)

About

ceo

Dr. James N. Woody M.D., Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://180lifesciences.com

exchange

NASDAQ

Description

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, Cali...

CIK

0001690080

ISIN

US68236V3024

CUSIP

68236V104

Address

Building 4

Phone

650 507 0669

Country

US

Employee

4

IPO Date

Jun 27, 2017

Summary

CIK

0001690080

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

68236V104

ISIN

US68236V3024

Country

US

Price

1.82

Beta

0.44

Volume Avg.

104.9k

Market Cap

1.55M

Shares

-

52-Week

1.33-27.93

DCF

1.73

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.03

P/B

-

Website

https://180lifesciences.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ATNF News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep